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1. Introduction 2. Experimental 
Non-enzymatically glycosylated proteins have 
gained wide interest as a contributing factor for the 
long-term secondary complications in subjects with 
diabetes mellitus. The most thoroughly investigated 
glycosylated protein is hemoglobin (HbA1c) (reviews 
[ 1,2]). The measurement of the glycosylated hemo- 
globin content is a valuable criterion in delineating 
treatment of diabetic patients. Currently chromato- 
graphic (including HPLC) and chemical determination 
methods are used, both having slightly different argets 
[3-51. 
The condensation between glucose and protein 
amino groups and the subsequent rearrangement reac- 
tions (scheme 1) take place at very different rates [6]. 
It is of prime importance to establish which of the 
glycosylated products of the reaction sequence is
determined by a given method. To determine the con- 
figuration of the bound glucose moiety we have used 
phefiylhydrazine asa reagent for keto-groups. The 
absence of detectable keto-groups in the l-amino-l- 
deoxy-fructose moiety shows that these glyco-groups 
are in a ring structure. 
Purification of hemoglobin A and A1C was done as 
in [7]. This preparation was used without further 
purification. Heine-free globin was obtained as in [8]. 
If the globin was still brownish, the precipitation step 
was repeated. Reaction of keto-groups with phenyl- 
hydrazine was done by a simplification of the proce- 
dure in [9]. Globin (10 rag, 0.6 tool) were dissolved in 
1 ml 6 M guanidine in 10 mM phosphate (pH 7.0). To 
this solution 100/~1 (~1 retool) phenylhydrazine w re 
added. After incubation for 30 rain at 37°C the 
samples were passed through aSephadex G-15 column 
(1.5 × 10 cm). Fractions containing the protein were 
brought o a concentration giving an absorption read- 
ing at 280 nm of ~1.1. Spectra between 260 and 550 
nm were recorded for each sample. 
The glyceraldehyde-modified h moglobin A, which 
was used as control for keto-group detection, was 
obtained according to [9]. Globin from this prepara- 
tion was difficult to dissolve in the guanidine-phos- 
phate buffer. It was therefore freed from insoluble 
material by centrifugation prior to the incubation 
with phenylhydrazine. 
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The protein concentration was determined accord- 
ing to [10] using the protein assay kit by Bio-Rad. 
Globin served as standard protein. 
3. Results and discussion 
Chemical reactions with group-specific agents are 
in use to elucidate chemical [9] and stereochemical 
[ 11 ] structures of native and modified hemoglobins. 
The phenylhydrazine reaction was used in [9] to 
detect he keto-amine-group in glyceraldehyde- 
treated hemoglobin and to monitor the Amadori 
rearrangement of the glyceraldehyde-hemoglobin- 
Schiff'base adduct. 
Here we applied the same reaction in order to 
search for keto-groups in the glycosylated hemoglobin 
fraction (HbAlc). In fig.1 the UV-VIS spectra of the 
phenylhydrazine-treated globins A and at identical 
concentrations A1C are shown. In both cases, no sig- 
nificant formation of hydrazone, which would absorb 
around 350 nm, was observed. 
Increasing the temperature, the concentration f
phenylhydrazine or the incubation time, did not lead 
to the formation of the hydrazone product. Globin 
from hemoglobin premodified with glyceraldehyde, 
however, exhibits after treatment with phenylhydra- 
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Fig.1. UV-VIS spectra of native globins after treatment with 
phenylhydrazine: ( - - )  globin A; ( - - - )  globin A1C. Inset: 
UV-Spectrum of a 0.001% phenylhydrazine solution in 0.1 M 
acetic acid. 
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Fig.2. UV-VIS spectra of phenylhydrazine-treated globins, 
pre-reacted with glyceraldehyde: ( - - )  globin A; ( - - - )  
globin A1C. 
zine an elevated absorption around 350 nm, which is 
also found to a lesser extent in premodified globin 
A1C after the same treatment (fig.2). 
The samples were adjusted to the same protein 
concentration using extinction at 280 nm. Traces of 
unbound phenylhydrazine present in the sample 
would influence the absorption ratio 280/350 (fig.l 
inset). Therefore the protein concentration was also 
determined colorimetrically. Since this determina- 
tion gave the same protein concentration, contamina- 
tion by phenylhydrazine can be excluded. 
The finding of a difference in absorption at 350 
nm between modified globin A and A1C after phenyl- 
hydrazine treatment reflects the blocked a-amino- 
group at the N-terminus of the/~-chain hemoglobin 
AlC which no longer binds glyceraldehyde. Conse- 
quently, e-amino-groups of lysines as well as the 
N-terminal a-amino-group of the c~-chain are the 
remaining candidates for these modifications [12]. 
Scheme 2 outlines the reaction sequence of the 
rearrangement from the open to the ring form of the 
carbohydrate moiety ofHbA1c (ka and k2) and that 
of the reaction from phenylhydrazine with the keto- 
amine of the open form (ka). The lack of detectable 
keto-groups in HbAlc can be explained either by 
k] >> k2 or k3 ~ k~. The latter explanation seems 
unlikely since, even upon prolonged incubation of 
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Chemical detection therefore requires drastic reaction 
conditions uch as heating with acid or oxidation in 
order to detect he derivatives thereby formed. 
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phenylhydrazine with the protein, no hydrazone 
derivative could be demonstrated. Furthermore, in
glyceraldehyde-treated hemoglobin, which does not 
have a rearrangement from an open to a ring form, 
keto-groups were easily detected with this method. 
Other evidence, indicating the presence of a ring- 
formed glucose derives from [13]. In their work anti- 
bodies against native HbA1c showed a much weaker 
binding to borohydride-reduced HbA1c in which the 
glucose is present in an open form. Furthermore, in
[14] upon periodate oxidation of the glycosylated 
hemoglobin, only 1 tool formaldehyde/mol glyco- 
group formed. Periodate treatment of an open glu- 
cose would liberate 2 molecules of formaldehyde. 
These findings show that direct chemical demon- 
stration of the protein-bound glucose is difficult. 
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